Trophic effects of selegiline on cultured dopaminergic neurons

Brain Research

Volumn 829, Issue 1-2, 1999, Pages 190-192

  Kontkanen, Outi ^a   Castrén, Eero ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Brain derived neurotrophic factor; L Deprenyl; Neurite outgrowth; Neurotrophic; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; SELEGILINE;

ANIMAL CELL; ARTICLE; DOPAMINERGIC NERVE CELL; DRUG EFFECT; DRUG MECHANISM; NERVE FIBER GROWTH; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; DOPAMINE; NERVE GROWTH FACTORS; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SELEGILINE;

EID: 0033594804     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(99)01363-3     Document Type: Article

References (15)

1. Beck K.D., Knusel B., Hefti F. The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture. Neuroscience. 52:1993;855-866.
2. Brewer G.J., Cotman C.W. Survival and growth of hippocampal neurons in defined medium at low density: advantages of a sandwich culture technique or low oxygen. Brain Res. 494:1989;65-74.
3. Cohen G., Spina M.B. Deprenyl suppresses the oxidant stress associated with increased dopamine turnover. Ann. Neurol. 26:1989;689-690.
4. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
5. Iwasaki Y., Ikeda K., Shiojima T., Kobayashi T., Tagaya N., Kinoshita M. Deprenyl enhances neurite outgrowth in cultured rat spinal ventral horn neurons. J. Neurol. Sci. 125:1994;11-13.
6. Kofman O.S. Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease. The Parkinson study group [see comments]. New Engl. J. Med. 328:1993;176-183.
7. Koutsilieri E., O'Callaghan J.F., Chen T.S., Riederer P., Rausch W.D. Selegiline enhances survival and neurite outgrowth of MPP(+)-treated dopaminergic neurons. Eur. J. Pharmacol. 269:1994;R3-R4.
8. Mytilineou C., Cohen G. Deprenyl protects dopamine neurons from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion. J. Neurochem. 45:1985;1951-1953.
9. Mytilineou C., Leonardi E.K., Radcliffe P., Heinonen E.H., Han S.K., Werner P., Cohen G., Olanow C.W. Deprenyl and desmethylselegiline protect mesencephalic neurons from toxicity induced by glutathione depletion. J. Pharmacol. Exp. Ther. 284:1998;700-706.
10. Mytilineou C., Radcliffe P., Leonardi E.K., Werner P., Olanow C.W. L-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro. J. Neurochem. 68:1997;33-39.
11. Roy E., Bedard P.J. Deprenyl increases survival of rat foetal nigral neurones in culture. NeuroReport. 4:1993;1183-1186.
12. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's disease cooperative study [see comments]. New Engl. J. Med. 336:1997;1216-1222.
13. Seroogy K.B., Lundgren K.H., Tran T.M., Guthrie K.M., Isackson P.J., Gall C.M. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs. J. Comp. Neurol. 342:1994;321-334.
14. Studer L., Spenger C., Seiler R.W., Altar C.A., Lindsay R.M., Hyman C. Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra. Eur. J. Neurosci. 7:1995;223-233.
15. Tatton W.G., Greenwood C.E. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J. Neurosci. Res. 30:1991;666-672.